EU regulator starts real-time review of Merck's COVID-19 pill

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. AMZN

Go back to EU regulator starts real-time review of Merck's COVID-19 pill
Merck & Co. (NYSE: MRK) Delayed: 147.15 --0 (-0%)
Previous Close $147.15    52 Week High $65.46 
Open $147.15    52 Week Low $47.97 
Day High $147.15    P/E 100.10 
Day Low $147.15    EPS $1.47 
Volume 6,452